Impaired hypothalamic Fto expression in response to fasting and glucose in obese mice

Nutrition and Diabetes

Volumn 1, Issue 10, 2011, Pages

  Poritsanos, N J ^a   Lew, P S ^a   Fischer, J ^b   Mobbs, C V ^c   Nagy, J I ^a   Wong, D ^a   Ruther U ^b   Mizuno, T M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Feeding; Gene expression; Hypothalamus; Nutrient; Obesity

Indexed keywords

EID: 84882986373     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2011.15     Document Type: Article

References (44)

1. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894.
2. Fawcett KA, Barroso I. The genetics of obesity: FTO leads the way. Trends Genet 2010; 26: 266-274.
3. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Bruning JC et al. Inactivation of the Fto gene protects from obesity. Nature 2009; 458: 894-898.
4. Church C, Lee S, Bagg EA, McTaggart JS, Deacon R, Gerken T et al. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genet 2009; 5: e1000599.
5. Church C, Moir L, McMurray F, Girard C, Banks GT, Teboul L et al. Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet 2010; 42: 1086-1092.
6. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS et al. The obesity-associated FTO gene encodes a 2-oxoglutaratedependent nucleic acid demethylase. Science 2007; 318: 1469-1472.
7. Stratigopoulos G, Padilla SL, LeDuc CA, Watson E, Hattersley AT, McCarthy MI et al. Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol 2008; 294: R1185-R1196.
8. Fredriksson R, Hagglund M, Olszewski PK, Stephansson O, Jacobsson JA, Olszewska AM et al. The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology 2008; 149: 2062-2071.
9. Olszewski PK, Fredriksson R, Olszewska AM, Stephansson O, Alsio J, Radomska KJ et al. Hypothalamic FTO is associated with the regulation of energy intake not feeding reward. BMC Neurosci 2009; 10: 129.
10. Stratigopoulos G, Leduc CA, Cremona ML, Chung WK, Leibel RL. Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated (FTO) and retinitis pigmentosa gtpase regulator interacting protein-1 like (RPGRIPIL) genes, and co-ordinates leptin receptor signaling. J Biol Chem 2010; 286: 2155-2170.
11. Tung YC, Ayuso E, Shan X, Bosch F, O'Rahilly S, Coll AP et al. Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS One 2010; 5: e8771.
12. Berthoud HR, Mogenson GJ. Ingestive behavior after intracerebral and intracerebroventricular infusions of glucose and 2-deoxy-D-glucose. Am J Physiol 1977; 233: R127-R133.
13. Davis JD, Wirtshafter D, Asin KE, Brief D. Sustained intracerebroventricular infusion of brain fuels reduces body weight and food intake in rats. Science 1981; 212: 81-83.
14. Le Feuvre RA, Woods AJ, Stock MJ, Rothwell NJ. Effects of central injection of glucose on thermogenesis in normal, VMH-lesioned and genetically obese rats. Brain Res 1991; 547: 110-114.
15. Molina PE, Eltayeb K, Hourani H, Okamura K, Nanney LB, Williams P et al. Hormonal and metabolic effects of neuroglucopenia. Brain Res 1993; 614: 99-108.
16. Lam TK, Gutierrez-Juarez R, Pocai A, Bhanot S, Tso P, Schwartz GJ et al. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat Med 2007; 13: 171-180.
17. Lam TK, Gutierrez-Juarez R, Pocai A, Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 2005; 309: 943-947.
18. Tsujii S, Bray GA. Effects of glucose, 2-deoxyglucose, phlorizin, and insulin on food intake of lean and fatty rats. Am J Physiol 1990; 258: E476-E481.
19. Song Z, Levin BE, McArdle JJ, Bakhos N, Routh VH. Convergence of pre-and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 2001; 50: 2673-2681.
20. Levin BE, Govek EK, Dunn-Meynell AA. Reduced glucose-induced neuronal activation in the hypothalamus of diet-induced obese rats. Brain Res 1998; 808: 317-319.
21. Matsuda M, Liu Y, Mahankali S, Pu Y, Mahankali A, Wang J et al. Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes 1999; 48: 1801-1806.
22. Kim ER, Leckstrom A, Mizuno TM. Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice. Behav Brain Res 2008; 194: 66-71.
23. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004; 428: 569-574.
24. Bergen HT, Monkman N, Mobbs CV. Injection with gold thioglucose impairs sensitivity to glucose: evidence that glucose-responsive neurons are important for long-term regulation of body weight. Brain Res 1996; 734: 332-336.
25. Poritsanos NJ, Wong D, Vrontakis ME, Mizuno TM. Regulation of hepatic PPARgamma2 and lipogenic gene expression by melanocortin. Biochem Biophys Res Commun 2008; 376: 384-388.
26. Poritsanos NJ, Lew PS, Mizuno TM. Relationship between blood glucose levels and hepatic Fto mRNA expression in mice. Biochem Biophys Res Commun 2010; 400: 713-717.
27. Sanchez-Pulido L, Andrade-Navarro MA. The FTO (fat mass and obesity associated) gene codes for a novel member of the nonheme dioxygenase superfamily. BMC Biochem 2007; 8: 23.
28. Jia G, Yang CG, Yang S, Jian X, Yi C, Zhou Z et al. Oxidative demethylation of 3-methylthymine and 3-methyluracil in singlestranded DNA and RNA by mouse and human FTO. FEBS Lett 2008; 582: 3313-3319.
29. Wu Q, Saunders RA, Szkudlarek-Mikho M, Serna Ide L, Chin KV. The obesity-associated Fto gene is a transcriptional coactivator. Biochem Biophys Res Commun 2010; 401: 390-395.
30. Dunn-Meynell AA, Govek E, Levin BE. Intracarotid glucose selectively increases Fos-like immunoreactivity in paraventricular, ventromedial and dorsomedial nuclei neurons. Brain Res 1997; 748: 100-106.
31. Wolfgang MJ, Cha SH, Sidhaye A, Chohnan S, Cline G, Shulman GI et al. Regulation of hypothalamic malonyl-CoA by central glucose and leptin. Proc Natl Acad Sci USA 2007; 104: 19285-19290.
32. Lee K, Li B, Xi X, Suh Y, Martin RJ. Role of neuronal energy status in the regulation of adenosine 5′-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. Endocrinology 2005; 146: 3-10.
33. Cai F, Gyulkhandanyan AV, Wheeler MB, Belsham DD. Glucose regulates AMP-activated protein kinase activity and gene expression in clonal, hypothalamic neurons expressing proopiomelanocortin: additive effects of leptin or insulin. J Endocrinol 2007; 192: 605-614.
34. Cheng H, Isoda F, Belsham DD, Mobbs CV. Inhibition of agoutirelated peptide expression by glucose in a clonal hypothalamic neuronal cell line is mediated by glycolysis, not oxidative phosphorylation. Endocrinology 2008; 149: 703-710.
35. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-252.
36. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM. Leptin prevents fasting-induced suppression of prothyrotropinreleasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997; 138: 2569-2576.
37. Isse T, Ueta Y, Serino R, Noguchi J, Yamamoto Y, Nomura M et al. Effects of leptin on fasting-induced inhibition of neuronal nitric oxide synthase mRNA in the paraventricular and supraoptic nuclei of rats. Brain Res 1999; 846: 229-235.
38. Fekete C, Singru PS, Sanchez E, Sarkar S, Christoffolete MA, Riberio RS et al. Differential effects of central leptin, insulin, or glucose administration during fasting on the hypothalamicpituitary-thyroid axis and feeding-related neurons in the arcuate nucleus. Endocrinology 2006; 147: 520-529.
39. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 1992; 130: 3608-3616.
40. Wang P, Yang FJ, Du H, Guan YF, Xu TY, Xu XW et al. Involvement of leptin receptor (LepRb)-STAT3 signaling pathway in brain FTO downregulation during energy restriction. Mol Med 2011; 17: 523-532.
41. Yang M, Zhang Y, Pan J, Sun J, Liu J, Libby P et al. Cathepsin L activity controls adipogenesis and glucose tolerance. Nat Cell Biol 2007; 9: 970-977.
42. Tournu C, Obled A, Roux MP, Deval C, Ferrara M, Bechet DM. Glucose controls cathepsin expression in Ras-transformed fibroblasts. Arch Biochem Biophys 1998; 360: 15-24.
43. Urbich C, Dernbach E, Rossig L, Zeiher AM, Dimmeler S. High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells. J Mol Cell Cardiol 2008; 45: 429-436.
44. Huang X, Vaag A, Carlsson E, Hansson M, Ahren B, Groop L. Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes. Diabetes 2003; 52: 2411-2418.